Official Month Underscores Impact of Lung Cancer, Highlights Urgent Need to Fund
Advanced Research as Hope Is on the Horizon
CHICAGO, Nov. 1, 2013 /PRNewswire-USNewswire/ -- This November, LUNGevity
Foundation, with the largest research awards program of any lung cancer-focused
organization in the U.S., recognizes Lung Cancer Awareness Month as a critical
time on our national calendar for addressing the impact of lung cancer in the
U.S. and around the world.
Lung cancer will strike 1 in 14 Americans in their lifetime, and more than 60%
of those diagnosed today are nonsmokers or former smokers. It is the leading
cause of cancer death, killing more people than breast, colon, pancreatic, and
prostate cancers combined. Lung Cancer Awareness Month, which began as Lung
Cancer Awareness Day in 1995, became an official designation as awareness
initiatives in the movement grew. The annual month-long observance reflects the
significant need for research funding and awareness in order to reduce lung
"Expanding awareness around lung cancer, and the importance of research, is
critical," said Andrea Ferris, President and Chairman of LUNGevity Foundation.
"The grim statistics--228,000 people will be diagnosed this year alone in the
U.S., and only 16% of those diagnosed are expected to survive 5 years or
more--are the result of long ignoring and underfunding research about this
disease. Yet, with a renewed commitment to innovative research, hope for the
future is very bright. We have already made encouraging strides; five years ago,
we could not have anticipated the enormous potential we see ahead in applying
scientific learnings to finding the disease earlier and treating it more
effectively. Through this official month of dialogue, we can continue to grow
our community of support and fuel the efforts to revolutionize how we detect and
treat lung cancer."
Since 2002, LUNGevity has funded projects representing more than $16 million
spent on 100 research projects at 56 institutions in 23 states and has connected
people to lung cancer survivorship through research, education, and support.
Throughout the year, LUNGevity coordinates grassroots and large-scale
initiatives with the goal of funding research in order to extend patients' lives
and improve quality of life post-diagnosis. The research is specifically focused
on expediting development of an effective early-detection strategy and
identifying therapeutic agents that provide customized genetic intervention for
"With LUNGevity's commitment to research and its ability to select the best
projects, there is tremendous momentum in the field of lung cancer research and
plenty of reason for hope in transforming outcomes," said Dr. Pierre Massion,
Chair of LUNGevity's Science Board. "From identifying biomarkers for the early
detection of the disease, to tumor genomic changes for targeted therapies, we
have the potential to make progress at unprecedented rates. Building more
awareness of the findings and the promise of science in improving outcomes for
this disease is an important first step."
LUNGevity will host a variety of educational, informational, and fundraising
programs and events throughout November. Activities will include:
-- A webinar to discuss current and evolving management issues in squamous
cell carcinoma, "Squamous Cell NSCLC: Growing Understanding and
Expanding Treatment Options" on November 12 at 2-3 pm Eastern, 11 am -
noon Pacific. RSVP at www.LUNGevity.org/webinars.
-- LUNGevity's longest-running event, the 2013 Fall Benefit on November 16
in Chicago, to raise funds for high-impact research, support, and
education programs. The Fall Benefit was LUNGevity's inaugural event in
2000. Since its inception, the event has raised more than $3.2 million
to fund the most promising lung cancer research in the world. For more
information, visit www.LUNGevity.org/fallbenefit.
-- Grassroots events throughout the national LUNGevity network to raise
funds for lifesaving lung cancer research and create awareness about the
disease. To find an event in your area, go to www.LUNGevity.org/events.
-- The first Regional Hope Summit to unite survivors of lung cancer,
November 8-9 at The Ohio State University Comprehensive Cancer Center.
The summit provides an opportunity for participants to celebrate lung
cancer survivorship and gives survivors the opportunity to learn,
collaborate, and connect/share their stories with other lung cancer
survivors. Register at www.lungevity.org/RegionalSummit.
For more information, please visit www.LUNGevity.org.
About Lung Cancer
-- 1 in 14 Americans is diagnosed with lung cancer in their lifetime.
-- About 60 percent of all new lung cancer diagnoses are among people who
have never smoked or are former smokers.
-- Lung cancer is the leading cause of cancer death, regardless of gender
-- Lung cancer kills almost twice as many women as breast cancer and more
than three times as many men as prostate cancer.
-- Only 16 percent of all people diagnosed with lung cancer will survive 5
years or more, but if it's caught before it spreads, the chance for
5-year survival improves to 52 percent.
About LUNGevity Foundation
LUNGevity Foundation is firmly committed to making an immediate impact on
increasing quality of life and survivorship of people with lung cancer by
accelerating research into early detection and more effective treatments, as
well as by providing community, support, and education for all those affected by
the disease. Our vision is a world where no one dies of lung cancer. For more
information about LUNGevity Foundation, please visit www.LUNGevity.org.
SOURCE LUNGevity Foundation